These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833 [TBL] [Abstract][Full Text] [Related]
4. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter. Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932 [TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas. Fults D; Pedone C Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623 [TBL] [Abstract][Full Text] [Related]
6. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844 [TBL] [Abstract][Full Text] [Related]
7. Functional evaluation of p53 and PTEN gene mutations in gliomas. Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241 [TBL] [Abstract][Full Text] [Related]
8. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052 [TBL] [Abstract][Full Text] [Related]
9. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672 [TBL] [Abstract][Full Text] [Related]
10. PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas. Fan X; Muñoz J; Sanko SG; Castresana JS Int J Oncol; 2002 Sep; 21(3):667-74. PubMed ID: 12168116 [TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913 [TBL] [Abstract][Full Text] [Related]
12. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Smith JS; Tachibana I; Passe SM; Huntley BK; Borell TJ; Iturria N; O'Fallon JR; Schaefer PL; Scheithauer BW; James CD; Buckner JC; Jenkins RB J Natl Cancer Inst; 2001 Aug; 93(16):1246-56. PubMed ID: 11504770 [TBL] [Abstract][Full Text] [Related]
13. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Liu W; James CD; Frederick L; Alderete BE; Jenkins RB Cancer Res; 1997 Dec; 57(23):5254-7. PubMed ID: 9393744 [TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247 [TBL] [Abstract][Full Text] [Related]
15. PTEN mutations in gliomas and glioneuronal tumors. Duerr EM; Rollbrocker B; Hayashi Y; Peters N; Meyer-Puttlitz B; Louis DN; Schramm J; Wiestler OD; Parsons R; Eng C; von Deimling A Oncogene; 1998 Apr; 16(17):2259-64. PubMed ID: 9619835 [TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Su TH; Chang JG; Perng LI; Chang CP; Wei HJ; Wang NM; Tsai CH Gynecol Oncol; 2000 Feb; 76(2):193-9. PubMed ID: 10637069 [TBL] [Abstract][Full Text] [Related]